JD HEALTH INTL LTD (8ZN) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.004x

Based on the latest financial reports, JD HEALTH INTL LTD (8ZN) has a cash flow conversion efficiency ratio of 0.004x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€184.04 Million ≈ $215.16 Million USD) by net assets (€48.69 Billion ≈ $56.93 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of JD HEALTH INTL LTD to measure how much of total assets are equity-financed.

JD HEALTH INTL LTD - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how JD HEALTH INTL LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 8ZN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

JD HEALTH INTL LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JD HEALTH INTL LTD ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mid-America Apartment Communities Inc NYSE:MAA	0.026x
Huagong Tech Co Ltd SHE:000988	0.040x
Mizrahi Tefahot TA:MZTF	0.036x
Nippon Sanso Holdings Corp. NYSE:NPXYY	0.076x
Peric Special Gases Co. Ltd. A SHG:688146	N/A
CG Power and Industrial Solutions Limited NSE:CGPOWER	0.059x
WESCO International Inc NYSE:WCC	0.043x
BWX Technologies Inc NYSE:BWXT	0.072x

Annual Cash Flow Conversion Efficiency for JD HEALTH INTL LTD (2019–2025)

The table below shows the annual cash flow conversion efficiency of JD HEALTH INTL LTD from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see 8ZN stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€60.07 Billion ≈ $70.23 Billion	€10.17 Billion ≈ $11.89 Billion	0.169x	+115.95%
2024-12-31	€55.24 Billion ≈ $64.58 Billion	€4.33 Billion ≈ $5.06 Billion	0.078x	-15.91%
2023-12-31	€49.37 Billion ≈ $57.72 Billion	€4.60 Billion ≈ $5.38 Billion	0.093x	-29.26%
2022-12-31	€44.78 Billion ≈ $52.36 Billion	€5.91 Billion ≈ $6.90 Billion	0.132x	+53.18%
2021-12-31	€39.85 Billion ≈ $46.59 Billion	€3.43 Billion ≈ $4.01 Billion	0.086x	-8.67%
2020-12-31	€39.25 Billion ≈ $45.89 Billion	€3.70 Billion ≈ $4.33 Billion	0.094x	+110.57%
2019-12-31	€-459.03 Million ≈ $-536.66 Million	€409.47 Million ≈ $478.71 Million	-0.892x	--

About JD HEALTH INTL LTD

F:8ZN Germany Pharmaceutical Retailers

Market Cap

$15.72 Billion

€13.44 Billion EUR

Market Cap Rank

#1571 Global

#343 in Germany

Share Price

€4.19

Change (1 day)

-0.52%

52-Week Range

€3.55 - €7.70

All Time High

€22.34